CN112557566A - 一种米格列奈钙中间体s-苄基琥珀酸的对应异构体的检测方法 - Google Patents
一种米格列奈钙中间体s-苄基琥珀酸的对应异构体的检测方法 Download PDFInfo
- Publication number
- CN112557566A CN112557566A CN202011449963.1A CN202011449963A CN112557566A CN 112557566 A CN112557566 A CN 112557566A CN 202011449963 A CN202011449963 A CN 202011449963A CN 112557566 A CN112557566 A CN 112557566A
- Authority
- CN
- China
- Prior art keywords
- mobile phase
- benzylsuccinic acid
- acid
- shaking
- benzylsuccinic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- GTOFKXZQQDSVFH-VIFPVBQESA-N (r)-2-benzylsuccinate Chemical compound OC(=O)C[C@@H](C(O)=O)CC1=CC=CC=C1 GTOFKXZQQDSVFH-VIFPVBQESA-N 0.000 title claims abstract description 34
- 229960003365 mitiglinide Drugs 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 21
- PMRVFZXOCRHXFE-FMEJWYFOSA-L Kad 1229 Chemical compound [Ca+2].C([C@@H](CC(=O)N1C[C@@H]2CCCC[C@@H]2C1)C(=O)[O-])C1=CC=CC=C1.C([C@@H](CC(=O)N1C[C@@H]2CCCC[C@@H]2C1)C(=O)[O-])C1=CC=CC=C1 PMRVFZXOCRHXFE-FMEJWYFOSA-L 0.000 title claims abstract 9
- GTOFKXZQQDSVFH-SECBINFHSA-N (R)-2-benzylsuccinic acid Chemical compound OC(=O)C[C@H](C(O)=O)CC1=CC=CC=C1 GTOFKXZQQDSVFH-SECBINFHSA-N 0.000 claims abstract description 51
- 239000000243 solution Substances 0.000 claims abstract description 50
- 238000005303 weighing Methods 0.000 claims abstract description 32
- 239000012085 test solution Substances 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 19
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 10
- 238000001914 filtration Methods 0.000 claims abstract description 10
- 238000007865 diluting Methods 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000012360 testing method Methods 0.000 claims abstract description 5
- 239000000706 filtrate Substances 0.000 claims abstract description 4
- 238000010606 normalization Methods 0.000 claims abstract description 4
- 238000004090 dissolution Methods 0.000 claims abstract description 3
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 3
- 238000001514 detection method Methods 0.000 claims description 18
- 239000013558 reference substance Substances 0.000 claims description 18
- BJTZQANDAMBQRV-UHFFFAOYSA-N hexane;propan-2-ol;2,2,2-trifluoroacetic acid Chemical compound CC(C)O.CCCCCC.OC(=O)C(F)(F)F BJTZQANDAMBQRV-UHFFFAOYSA-N 0.000 claims description 10
- WPGGHFDDFPHPOB-BBWFWOEESA-N mitiglinide Chemical compound C([C@@H](CC(=O)N1C[C@@H]2CCCC[C@@H]2C1)C(=O)O)C1=CC=CC=C1 WPGGHFDDFPHPOB-BBWFWOEESA-N 0.000 claims description 8
- 239000012088 reference solution Substances 0.000 abstract description 9
- 238000000926 separation method Methods 0.000 description 17
- QEVLNUAVAONTEW-UZYHXJQGSA-L calcium;(2s)-4-[(3as,7ar)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoate;dihydrate Chemical compound O.O.[Ca+2].C([C@@H](CC(=O)N1C[C@@H]2CCCC[C@@H]2C1)C(=O)[O-])C1=CC=CC=C1.C([C@@H](CC(=O)N1C[C@@H]2CCCC[C@@H]2C1)C(=O)[O-])C1=CC=CC=C1 QEVLNUAVAONTEW-UZYHXJQGSA-L 0.000 description 14
- 239000000047 product Substances 0.000 description 10
- 238000012216 screening Methods 0.000 description 7
- 239000011259 mixed solution Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 230000003044 adaptive effect Effects 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000009210 therapy by ultrasound Methods 0.000 description 5
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- GTOFKXZQQDSVFH-UHFFFAOYSA-N 2-benzylsuccinic acid Chemical compound OC(=O)CC(C(O)=O)CC1=CC=CC=C1 GTOFKXZQQDSVFH-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- ARLZGEXVMUDUQZ-UHFFFAOYSA-N O.O.[Ca] Chemical compound O.O.[Ca] ARLZGEXVMUDUQZ-UHFFFAOYSA-N 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- -1 (3,5 dimethyl) phenyl Chemical group 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000009460 calcium influx Effects 0.000 description 1
- 230000003112 degranulating effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/884—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8872—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample impurities
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Description
流速,ml/min | 分离度 |
0.8 | 1.88 |
1.0 | 2.01 |
1.2 | 1.79 |
柱温,℃ | 分离度 |
25 | 2.03 |
30 | 2.08 |
35 | 1.99 |
仪器 | 型号 | 分离度 |
安捷伦高效液相色谱仪 | 1260 | 1.86 |
Waters高效液相色谱仪 | 2695 | 1.73 |
批号 | R |
191201 | 0.056% |
191202 | 0.074% |
类型 | 分离度 | 理论塔板数 |
实施例1 | 1.88 | 6805 |
实施例2 | 2.01 | 7337 |
实施例3 | 1.79 | 7159 |
实施例4 | 1.48 | 6904 |
实施例5 | 1.04 | 7012 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011449963.1A CN112557566A (zh) | 2020-12-12 | 2020-12-12 | 一种米格列奈钙中间体s-苄基琥珀酸的对应异构体的检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011449963.1A CN112557566A (zh) | 2020-12-12 | 2020-12-12 | 一种米格列奈钙中间体s-苄基琥珀酸的对应异构体的检测方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112557566A true CN112557566A (zh) | 2021-03-26 |
Family
ID=75061634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011449963.1A Pending CN112557566A (zh) | 2020-12-12 | 2020-12-12 | 一种米格列奈钙中间体s-苄基琥珀酸的对应异构体的检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112557566A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10195015A (ja) * | 1997-01-17 | 1998-07-28 | Nagase & Co Ltd | 2−ベンジルコハク酸化合物の光学分割方法 |
WO2002085833A1 (fr) * | 2001-04-18 | 2002-10-31 | Kuraray Co., Ltd. | Procede de preparation d'acide 2-benzyl-succinique a activite optique et de monamides de l'acide 2-benzyl-succinique a activite optique |
CN109580821A (zh) * | 2018-12-21 | 2019-04-05 | 山东铂源药业有限公司 | 一种s-苄基琥珀酸中杂质丁二酸的检测方法 |
CN110568100A (zh) * | 2019-09-12 | 2019-12-13 | 江西济民可信金水宝制药有限公司 | 一种米格列奈钙r-异构体的检测方法 |
-
2020
- 2020-12-12 CN CN202011449963.1A patent/CN112557566A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10195015A (ja) * | 1997-01-17 | 1998-07-28 | Nagase & Co Ltd | 2−ベンジルコハク酸化合物の光学分割方法 |
WO2002085833A1 (fr) * | 2001-04-18 | 2002-10-31 | Kuraray Co., Ltd. | Procede de preparation d'acide 2-benzyl-succinique a activite optique et de monamides de l'acide 2-benzyl-succinique a activite optique |
CN109580821A (zh) * | 2018-12-21 | 2019-04-05 | 山东铂源药业有限公司 | 一种s-苄基琥珀酸中杂质丁二酸的检测方法 |
CN110568100A (zh) * | 2019-09-12 | 2019-12-13 | 江西济民可信金水宝制药有限公司 | 一种米格列奈钙r-异构体的检测方法 |
Non-Patent Citations (3)
Title |
---|
姚其正 主编 * |
宋劲燕等: "高效液相色谱法用于米格列奈钙含量和有关物质的研究", 《科技情报开发与经济》 * |
张晓丽等: "米格列奈钙3个主要降解杂质的研究", 《中国药房》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109387587B (zh) | 一种l-2-氨基-5-胍基戊酸对映异构体的检测方法 | |
CN108181407B (zh) | 一种布洛芬原料杂质f的检测方法 | |
CN114113405A (zh) | 一种甘油磷酸胆碱及其异构体的高效液相色谱分析方法 | |
CN101285803B (zh) | 降糖中药类产品中非法掺入低极性降糖化学药物的定性分析检测方法 | |
CN112557566A (zh) | 一种米格列奈钙中间体s-苄基琥珀酸的对应异构体的检测方法 | |
CN110568100B (zh) | 一种米格列奈钙r-异构体的检测方法 | |
CN101285802B (zh) | 降糖中药类产品中非法掺入高极性降糖化学药物的定性分析检测方法 | |
CN111175389A (zh) | 一种高效液相色谱法检测中生菌素f的方法 | |
CN110412164A (zh) | 一种盐酸美西律的有关物质的检测方法 | |
CN115248260A (zh) | 一种苯磺顺阿曲库铵原料药中有关物质的hplc分析检测方法 | |
CN111007157B (zh) | 一种依鲁替尼制备过程中的纯度检测方法 | |
CN113640403A (zh) | 甲磺酸帕珠沙星原料药的含量检测方法 | |
CN106290683A (zh) | 一种检测金霉素发酵液中单质糖浓度的方法 | |
CN116930368B (zh) | 一种司替戊醇异构体的检测方法 | |
CN117330659B (zh) | 一种检测四肽非活化酯异构体的高效液相色谱分析方法 | |
CN111679004A (zh) | 一种普罗布考的质量控制方法 | |
CN113866322B (zh) | 一种反相高效液相色谱检测阿福拉纳中间体的方法 | |
CN116008443B (zh) | α5-GABAA受体调节剂类药物中有关物质的检测方法 | |
CN118090971A (zh) | 一种羊毛脂胆固醇粗品的检测方法 | |
CN114216987B (zh) | 高效液相色谱分析头孢克肟片的方法 | |
CN115166122B (zh) | 含非泼罗尼和甲氧普烯的复方制剂中甲氧普烯检测方法 | |
CN113092598B (zh) | 一种米格列醇中间体的检测方法 | |
CN116203172A (zh) | 一种达格列净sm-1中2-氯-4-溴苯甲酰氯的检测方法 | |
CN112924566B (zh) | 一种同时检测酶促反应液中甘氨酸和丝氨酸的方法 | |
CN117330659A (zh) | 一种检测四肽非活化酯异构体的高效液相色谱分析方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Xiaomin Inventor after: Li Yibao Inventor after: Ma Lixiong Inventor after: Peng Changchun Inventor after: Yi Yaojiang Inventor after: Liu Jin Inventor before: Chen Xiaomin Inventor before: Peng Changchun Inventor before: Yi Yaojiang Inventor before: Ma Lixiong |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210326 |